Cancer Therapy Advisor | Phase 1b Trial of Pre-surgery MEDI6469 for Head and Neck Cancer Cancer Therapy Advisor Description: For this phase 1b, non-randomized study, researchers are evaluating whether pre-surgery MEDI6469, an anti-OX40 antibody, will improve outcomes among patients with head and neck cancer. All enrolled patients will have loco-regionally ... |
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ujwgFb
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,